You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -201.4% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.7 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 5.7 | n/a |
| Price / Book value | 3.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -60.8% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | 3.90 | -1.07 | -3.20p | -29.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-03-31 | 4.16 | -1.26 | -0.12p | -1,364.4 | 0.0 | n/a | n/a | 0.0% |
| 2022-03-31 | 4.80 | -1.33 | -4.60p | -13.0 | 0.0 | n/a | n/a | 0.0% |
| 2023-03-31 | 2.90 | -2.86 | -10.00p | -3.8 | 0.0 | n/a | n/a | 0.0% |
| 2024-03-31 | 1.14 | -2.29 | -3.90p | -1.0 | 0.0 | n/a | n/a | 0.0% |
| Fusion Antibodies reports positive recent trading Sharecast News | 08 Oct |
|---|---|
| Fusion Antibodies strengthens financial position despite revenue decline Sharecast News | 05 Sep |
| Fusion Antibodies 'on track and on plan' following positive Q1 performance Sharecast News | 04 Jul |
| Approval of Grant Funding Application | 04-Dec-24 11:31 |
|---|---|
| Half-year Report | 19-Nov-24 07:01 |
| Director/PDMR Shareholding | 16-Oct-24 13:24 |
| Issue of shares to non-executive directors | 16-Oct-24 07:01 |
| Result of AGM | 08-Oct-24 12:33 |